U.S. flag

An official website of the United States government

NM_000527.5(LDLR):c.1243G>C (p.Asp415His) AND Familial hypercholesterolemia

Germline classification:
Pathogenic (2 submissions)
Last evaluated:
Dec 12, 2021
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001174782.4

Allele description [Variation Report for NM_000527.5(LDLR):c.1243G>C (p.Asp415His)]

NM_000527.5(LDLR):c.1243G>C (p.Asp415His)

Gene:
LDLR:low density lipoprotein receptor [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
19p13.2
Genomic location:
Preferred name:
NM_000527.5(LDLR):c.1243G>C (p.Asp415His)
HGVS:
  • NC_000019.10:g.11113334G>C
  • NG_009060.1:g.28954G>C
  • NM_000527.5:c.1243G>CMANE SELECT
  • NM_001195798.2:c.1243G>C
  • NM_001195799.2:c.1120G>C
  • NM_001195800.2:c.739G>C
  • NM_001195803.2:c.862G>C
  • NP_000518.1:p.Asp415His
  • NP_000518.1:p.Asp415His
  • NP_001182727.1:p.Asp415His
  • NP_001182728.1:p.Asp374His
  • NP_001182729.1:p.Asp247His
  • NP_001182732.1:p.Asp288His
  • LRG_274t1:c.1243G>C
  • LRG_274:g.28954G>C
  • LRG_274p1:p.Asp415His
  • NC_000019.9:g.11224010G>C
  • NM_000527.4:c.1243G>C
  • c.1243G>C
Protein change:
D247H
Links:
LDLR-LOVD, British Heart Foundation: LDLR_000538; dbSNP: rs879254844
NCBI 1000 Genomes Browser:
rs879254844
Molecular consequence:
  • NM_000527.5:c.1243G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001195798.2:c.1243G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001195799.2:c.1120G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001195800.2:c.739G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001195803.2:c.862G>C - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Familial hypercholesterolemia
Identifiers:
MONDO: MONDO:0005439; MedGen: C0020445; OMIM: PS143890

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001338113Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Pathogenic
(Jan 27, 2020)
germlineclinical testing

PubMed (6)
[See all records that cite these PMIDs]

Citation Link,

SCV003443160Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Dec 12, 2021)
germlineclinical testing

PubMed (5)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

The molecular basis of familial hypercholesterolemia in The Netherlands.

Fouchier SW, Defesche JC, Umans-Eckenhausen MW, Kastelein JP.

Hum Genet. 2001 Dec;109(6):602-15. Epub 2001 Nov 9.

PubMed [citation]
PMID:
11810272

LDLR Database (second edition): new additions to the database and the software, and results of the first molecular analysis.

Varret M, Rabés JP, Thiart R, Kotze MJ, Baron H, Cenarro A, Descamps O, Ebhardt M, Hondelijn JC, Kostner GM, Miyake Y, Pocovi M, Schmidt H, Schuster H, Stuhrmann M, Yamamura T, Junien C, Béroud C, Boileau C.

Nucleic Acids Res. 1998 Jan 1;26(1):248-52.

PubMed [citation]
PMID:
9399845
PMCID:
PMC147253
See all PubMed Citations (8)

Details of each submission

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV001338113.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (6)

Description

Variant summary: LDLR c.1243G>C (p.Asp415His) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 251172 control chromosomes (gnomAD). c.1243G>C has been reported in the literature in individuals affected with Familial Hypercholesterolemia (examples- Fouchier_2001, VanGaal_2001, Huijgen_2012, Kusters_2013, Sanna_2016). These data indicate that the variant is likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Two other ClinVar submitters (evaluation after 2014) have cited the variant as pathogenic/likely pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Labcorp Genetics (formerly Invitae), Labcorp, SCV003443160.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (5)

Description

This variant is also known as D394H. This missense change has been observed in individual(s) with familial hypercholesterolemia (PMID: 11851376, 22390909, 26894473). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces aspartic acid, which is acidic and polar, with histidine, which is basic and polar, at codon 415 of the LDLR protein (p.Asp415His). ClinVar contains an entry for this variant (Variation ID: 251748). For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Asp415 amino acid residue in LDLR. Other variant(s) that disrupt this residue have been observed in individuals with LDLR-related conditions (PMID: 23375686), which suggests that this may be a clinically significant amino acid residue. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024